According to Incyte's latest financial reports the company has $5.18 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $5.18 B | 18.76% |
2022-12-31 | $4.37 B | 15.92% |
2021-12-31 | $3.77 B | 44.37% |
2020-12-31 | $2.61 B | 0.49% |
2019-12-31 | $2.59 B | 34.91% |
2018-12-31 | $1.92 B | 18.11% |
2017-12-31 | $1.63 B | 288.74% |
2016-12-31 | $0.41 B | 145.08% |
2015-12-31 | $0.17 B | -309.68% |
2014-12-31 | $-81.63 M | -57.73% |
2013-12-31 | $-0.2 B | 10.37% |
2012-12-31 | $-0.18 B | -22.95% |
2011-12-31 | $-0.23 B | 156.17% |
2010-12-31 | $-88.65 M | -13.42% |
2009-12-31 | $-0.11 B | -53.62% |
2008-12-31 | $-0.23 B | 38.39% |
2007-12-31 | $-0.16 B | 87.87% |
2006-12-31 | $-84.91 M | 337.74% |
2005-12-31 | $-19.4 M | -124.7% |
2004-12-31 | $78.51 M | -49.12% |
2003-12-31 | $0.15 B | -48.97% |
2002-12-31 | $0.30 B | -31.3% |
2001-12-31 | $0.44 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $46.75 B | 800.80% | ๐จ๐ญ Switzerland |
Pfizer PFE | $89.28 B | 1,620.44% | ๐บ๐ธ USA |
Eli Lilly LLY | $10.86 B | 109.33% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | 20.08% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $0.70 B | -86.49% | ๐บ๐ธ USA |
Geron GERN | $0.24 B | -95.22% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | -$25.35 M | -100.49% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $28.84 M | -99.44% | ๐บ๐ธ USA |
Ardelyx ARDX | $0.16 B | -96.79% | ๐บ๐ธ USA |